Influence of sCD40L on gastric cancer cell lines

Mol Biol Rep. 2011 Nov;38(8):5459-64. doi: 10.1007/s11033-011-0702-9. Epub 2011 Mar 20.

Abstract

The CD40 signaling pathway plays a key role in tumor cell proliferation, differentiation, and apoptosis. Gastric cancer usually possesses a higher level of CD40 expression than normal tissue. We evaluated inhibition of soluble CD40 ligand (sCD40L) in apoptosis induction of gastric cancer cells. Gastric cancer cells (AGS and BGC-823) were incubated with sCD40L. Cell viability and cell cycle were determined by methyl-tetrazolium (MTT) assay and flow cytometry, respectively. The results showed that sCD40L hindered cell growth, arrested cells at G0/G1 phase and induced apoptosis. In conclusion, sCD40L suppress growth of gastric cancer cells through apoptosis induction and cell cycle quiescence. This work will provided a new approach to gene therapy of gastric cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Biological Assay
  • CD40 Ligand / pharmacology*
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cell Shape / drug effects
  • Cell Survival / drug effects
  • Humans
  • Solubility / drug effects
  • Stomach Neoplasms / pathology*

Substances

  • CD40 Ligand